Print

HVTN 114; GOVX-B11

Trial Details:

I Ongoing
National Institute of Allergy and Infectious Diseases (NIAID) January 01, 2017
AIDSVAX B/E,MVA/HIV62 Protein Env B,E; Pox Gag, Evn, Pol B
AIDSVAX B/E Protein
MVA/HIV62 Viral Vector - Pox
USA 100
NCT02852005
https://www.clinicaltrials.gov/ct2/show/NCT02852005